← Leaderboards
David J Waxman
Boston University Medical Campus
$23,862,644
Attributed
$24,274,971
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,274,971 · 10
By mechanism
R01$21,529,884 · 6
P42$1,646,381 · 2
RC1$892,456 · 1
R56$206,250 · 1
Top collaborators
- Rhonda D. Kineman1 shared
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingLiverGene ExpressionGenesTranscription FactorHepaticMetabolismEnzymesCytochrome P450Epigenetic ProcessLiver MetabolismChromatinIn VivoComplexMouse ModelPathway InteractionsGenomicsPatternPharmaceutical PreparationsSomatotropinEnvironmentEndocrineMaleRegulation
Grant awards (80)
MASLD protection by STAT5-regulated transcription factors$824,655
R01 · FY2025 · DK
Xenobiotic-responsive hepatic long non-coding RNAs$471,971
R01 · FY2024 · ES · contact PI
Xenobiotic-responsive hepatic long non-coding RNAs$77,783
R01 · FY2024 · ES · contact PI
Growth Hormone Regulation of Sex Differences in Liver Metabolism$496,343
R01 · FY2023 · DK · contact PI
Xenobiotic-responsive hepatic long non-coding RNAs$471,971
R01 · FY2023 · ES · contact PI
Xenobiotic-responsive hepatic long non-coding RNAs$77,783
R01 · FY2023 · ES · contact PI
Xenobiotic-responsive hepatic long non-coding RNAs$34,889
R01 · FY2023 · ES · contact PI
Growth Hormone Regulation of Sex Differences in Liver Metabolism$494,977
R01 · FY2022 · DK · contact PI
Xenobiotic-responsive hepatic long non-coding RNAs$471,971
R01 · FY2022 · ES · contact PI
Growth Hormone Regulation of Sex Differences in Liver Metabolism$493,652
R01 · FY2021 · DK · contact PI
Xenobiotic-responsive hepatic long non-coding RNAs$471,971
R01 · FY2021 · ES · contact PI
Growth Hormone Regulation of Sex Differences in Liver Metabolism$503,133
R01 · FY2020 · DK · contact PI
Xenobiotic-responsive hepatic long non-coding RNAs$471,971
R01 · FY2020 · ES · contact PI
Growth Hormone Regulation of Sex Differences in Liver Metabolism$491,118
R01 · FY2019 · DK · contact PI
Epigenetic Actions of Environmental Chemicals$403,884
R01 · FY2018 · ES · contact PI
Regulation of sex differences in liver metabolism$206,250
R56 · FY2018 · DK · contact PI
Regulation of Sex Differences in Liver Metabolism$481,222
R01 · FY2017 · DK · contact PI
Epigenetic Actions of Environmental Chemicals$403,884
R01 · FY2017 · ES · contact PI
Regulation of Sex Differences in Liver Metabolism$532,861
R01 · FY2016 · DK · contact PI
Epigenetic Actions of Environmental Chemicals$403,884
R01 · FY2016 · ES · contact PI
Regulation of Sex Differences in Liver Metabolism$515,633
R01 · FY2015 · DK · contact PI
Epigenetic Actions of Environmental Chemicals$403,884
R01 · FY2015 · ES · contact PI
Regulation of Sex Differences in Liver Metabolism$28,608
R01 · FY2015 · DK · contact PI
Regulation of Sex Differences in Liver Metabolism$546,761
R01 · FY2014 · DK · contact PI
Epigenetic Actions of Environmental Chemicals$403,884
R01 · FY2014 · ES · contact PI
Combination Therapies for Cancer Treatment$318,393
R01 · FY2014 · CA · contact PI
Regulation of Sex Differences in Liver Metabolism$100,000
R01 · FY2014 · DK · contact PI
Regulation of Sex Differences in Liver Metabolism$481,222
R01 · FY2013 · DK · contact PI
Combination Therapies for Cancer Treatment$308,545
R01 · FY2013 · CA · contact PI
Regulation of Sex Differences in Liver Metabolism$31,128
R01 · FY2013 · DK · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$462,982
R01 · FY2012 · DK · contact PI
Combination Therapies for Cancer Treatment$328,240
R01 · FY2012 · CA · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$477,414
R01 · FY2011 · DK · contact PI
Combination Therapies for Cancer Treatment$328,240
R01 · FY2011 · CA · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$557,729
R01 · FY2010 · DK · contact PI
Epigenetic Marks of Xenoestrogen Exposure$410,550
RC1 · FY2010 · ES · contact PI
Combination Therapies for Cancer Treatment$338,392
R01 · FY2010 · CA · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$100,001
R01 · FY2010 · DK · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$95,855
R01 · FY2010 · DK · contact PI
Epigenetic Marks of Xenoestrogen Exposure$80,953
RC1 · FY2010 · ES · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$458,601
R01 · FY2009 · DK · contact PI
Epigenetic Marks of Xenoestrogen Exposure$400,953
RC1 · FY2009 · ES · contact PI
Research Project 3: Nuclear Receptors and Gonadal Toxicity of Xenochemicals$232,398
P42 · FY2009 · ES · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$75,834
R01 · FY2009 · DK · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$445,250
R01 · FY2008 · DK · contact PI
Hepatic Metabolism of Anti-cancer Drugs$275,637
R01 · FY2008 · CA · contact PI
Research Project 3: Nuclear Receptors and Gonadal Toxicity of Xenochemicals$233,643
P42 · FY2008 · ES · contact PI
Hepatic Metabolism of Anti-cancer Drugs$50,877
R01 · FY2008 · CA · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$445,000
R01 · FY2007 · DK · contact PI
Hepatic Metabolism of Anti-cancer Drugs$275,637
R01 · FY2007 · CA · contact PI
Research Project 3: Nuclear Receptors and Gonadal Toxicity of Xenochemicals$207,848
P42 · FY2007 · ES · contact PI
Hepatic Metabolism of Anti-cancer Drugs$49,584
R01 · FY2007 · CA · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$444,942
R01 · FY2006 · DK · contact PI
Hepatic Metabolism of Anti-cancer Drugs$283,869
R01 · FY2006 · CA · contact PI
Research Project 3: Nuclear Receptors and Gonadal Toxicity of Xenochemicals$220,653
P42 · FY2006 · ES · contact PI
Hepatic Metabolism of Anti-cancer Drugs$48,327
R01 · FY2006 · CA · contact PI
Cytochrome P450-Endogenous Substrate Metabolism$442,378
R01 · FY2005 · DK
Hepatic Metabolism of Anti-cancer Drugs$290,700
R01 · FY2005 · CA
Research Project 3: Nuclear Receptors and Gonadal Toxicity of Xenochemicals$214,227
P42 · FY2005 · ES
Hepatic Metabolism of Anti-cancer Drugs$47,108
R01 · FY2005 · CA
Cytochrome P450-Endogenous Substrate Metabolism$429,491
R01 · FY2004 · DK
Hepatic Metabolism of Anti-cancer Drugs$290,700
R01 · FY2004 · CA
Hepatic Metabolism of Anti-cancer Drugs$42,636
R01 · FY2004 · CA
Cytochrome P450-Endogenous Substrate Metabolism$416,980
R01 · FY2003 · DK
HEPATIC METABOLISM OF ANTICANCER DRUGS$262,754
R01 · FY2003 · CA
CYTOCHROME P450--ENDOGENOUS SUBSTRATE METABOLISM$378,307
R01 · FY2002 · DK
HEPATIC METABOLISM OF ANTICANCER DRUGS$255,100
R01 · FY2002 · CA
NADPH P450 REDUCTASE--THYROID HORMONE REGULATION$213,246
R01 · FY2002 · DK
PPAR, hormones, and xenobiotics$134,403
P42 · FY2002 · ES
PPAR, hormones, and xenobiotics$134,403
P42 · FY2002 · ES
CYTOCHROME P450--ENDOGENOUS SUBSTRATE METABOLISM$5,868
R01 · FY2002 · DK
CYTOCHROME P450--ENDOGENOUS SUBSTRATE METABOLISM$369,728
R01 · FY2001 · DK
HEPATIC METABOLISM OF ANTICANCER DRUGS$249,889
R01 · FY2001 · CA
NADPH P450 REDUCTASE--THYROID HORMONE REGULATION$208,143
R01 · FY2001 · DK
PPAR, hormones, and xenobiotics$134,403
P42 · FY2001 · ES
CYTOCHROME P450--ENDOGENOUS SUBSTRATE METABOLISM$361,402
R01 · FY2000 · DK
HEPATIC METABOLISM OF ANTICANCER DRUGS$244,826
R01 · FY2000 · CA
NADPH P450 REDUCTASE--THYROID HORMONE REGULATION$203,186
R01 · FY2000 · DK
PPAR, hormones, and xenobiotics$134,403
P42 · FY2000 · ES
CYTOCHROME P450--ENDOGENOUS SUBSTRATE METABOLISM$57,050
R01 · FY2000 · DK